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ABSTRACT: 
 
Background:  Chronic  ethanol  ingestion
  causes  hepatic  damage  imputable  to  an  increased 
oxidative  stress  engendered  by  alcoholic  toxicity.  Polyphenols  in  cocoa  have  antioxidant 
properties,  and  natural  cocoa  powder  (NCP)  contains  the  highest  levels  of  total  antioxidant 
capacity  when  compared  to  all  other  kinds  of  edible  cocoa  products.  This  study  tested  the 
hypothesis that dietary supplementation
 with NCP mitigates hepatic injury resulting
 from chronic 
ethanol consumption. Three groups of eight randomized Sprague-Dawley rats were fed standard 
rat  food  and  treated  daily  for  12  weeks  as  follows:  (i)  the  Ethanol-water  group  was  given 
unrestricted  access  to  40%  (v/v)  ethanol  for  12  hours  (at  night)  followed  by  water  for  the 
remaining 12 hours (daytime), (ii) the Ethanol-cocoa group had similarly unrestricted access to 
40% ethanol for 12 hours followed by 2% (w/v) NCP for 12 hours, and (iii) the control group 
was  not  given  alcohol  and  had  unrestricted  access  to  only  water  which  was  synchronously 
replenished every 12 hours as it was for the ethanol treated animals. 
 
Results:  Qualitative  structural  liver  damage  evidenced  by  hepatocyte  cytoplasmic  fatty 
accumulation, nuclear alterations, and disruption of general liver micro-architecture, was severe 
in the ethanol-water group when compared with the ethanol-cocoa group of rats. Design-based 
stereologic assessment  yielded a significantly greater volume (Tukey’s HSD, p = 0.0005) of 
undamaged hepatocytes (9.61 ml, SD 2.18 ml)
 in the ethanol-cocoa group as opposed to the
 
ethanol-water group of rats (2.34 ml, SD 1.21 ml).  Control rats had 10.34 ml (SD 1.47 ml) of 
undamaged hepatocytes, and that was not significantly greater (Tukey’s HSD, p=0.659) than the 
value for the ethanol-cocoa group of rats.  Relative to controls, therefore, histomorphometry Functional Foods in Health and Disease 2012, 2(5):166- 187                                                           Page 167 of 187 
 
showed 93% hepatocyte preservation from alcoholic injury in rats that voluntarily imbibed NCP 
suspension compared with 23% in animals that drank water. 
 
Conclusions: Ethanol-induced structural liver injury was qualitatively and quantitatively milder 
in rats which chronically imbibed alcohol then afterward drank NCP beverage in place of water. 
The  antioxidant  and  anti-inflammatory  properties  of  polyphenols  in  NCP  are  postulated  in 
mitigating the damage of rat liver due to chronic ethanol consumption.  Thus, it is suggested 
from these findings that regular drinking of NCP beverage may slow progression of alcoholic 
liver disease in dipsomaniacs. 
 
Key  words:  natural  cocoa  powder,  chronic  alcoholic  toxicity,  total  antioxidant  capacity, 
polyphenols 
 
 
BACKGROUND: 
Substantial experimental and clinical evidence support a causative role of oxidative stress in the 
pathophysiological processes of liver injury [1, 2] resulting from excessive alcohol ingestion [3].  
The liver is most liable to the damaging effects of chronic alcohol consumption because it is the 
site of alcohol metabolism via a cascade of biochemical processes [4].  When the metabolic 
pathway for alcohol is overly taxed, an excessive amount of reactive oxygen species (ROS) is 
generated  [5]  which  causes  oxidative  stress  consequent  to  the  compromised  endogenous 
antioxidant capacity of hepatocytes [6].  Being the parenchymal cells which make up the bulk of 
liver  structure,  hepatocytes  are  particularly  susceptible  to  the  oxidative  and  inflammatory 
challenges of both acute and chronic ethanol toxicity [3].  The ultimate damage of hepatocytes 
due to ethanol metabolism validates concomitant poor growth indices and impairment of liver 
function in humans and experimental animals [7]. Given the integral involvement of xenobiotic 
pathways in amplifying the debilitating effect of alcohol on the liver, interventions suggested that 
to fend off the vulnerability of the liver to oxidative challenges during alcohol consumption one 
must reinforce the endogenous antioxidant defense systems [6, 8, 9].   Liver damage due to 
alcoholic  toxicity  includes  elevated  serum  alanine  transaminase  (ALT)  and  aspartate 
transaminase (AST) levels [10,11].  Other workers [13] have noted that hepatic damage is also 
characterized by markedly elevated levels of alanine transaminase (ALT), aspartate transaminase 
(AST) and bilirubin, coupled with a marked hepatic oxidative stress. 
Cocoa  contains  polyphenols,  which  are  beneficial  compounds  found  in  many  fruits, 
vegetables, teas, and wines [14].  The polyphenols found in cocoa are called flavanols, which 
have potent antioxidant properties. These polyphenols also include catechins, epicatechins, and 
procyanidins [15], which are known to exert anti-inflammatory effects [16]. Epidemiological 
studies  and  anecdotal  observations  have  primarily  ascribed  the  health  benefits  of  cocoa 
consumption  to  its  high  antioxidant  content.  Notable  among  these  many  health  benefits  are 
cocoa’s  hypothesized  antimalarial  prophylactic  effect  [17].  Cocoa  consumption  also  plays  a 
preventative role in cardiovascular protection [14] and also against tumoural and carcinogenic 
processes  [18,  19].  The  modulation  of  oxidative  stress  by  cocoa  polyphenols  has  been Functional Foods in Health and Disease 2012, 2(5):166- 187                                                           Page 168 of 187 
 
demonstrated in many experimental models. Furthermore, different mechanisms of activity have 
been established within this main effect for both cocoa products and for isolated flavanols [20, 
21]. 
The antioxidant properties of flavanols are ascribed partly to their structural characteristics, 
including the oligomeric chain length and the stereochemical features of the molecule. These 
structural characteristics of flavanols represent the molecular basis for their radical-scavenging 
(antioxidative) property [22, 23].  Long term feeding studies of flavanol-rich cocoa showed an 
increase  in  total  plasma  antioxidant  capacity  and  a  reduction  in  susceptibility  to  oxidative 
injuries [14]. What’s more, cocoa powder and it’s extracts have been shown to exhibit a greater 
antioxidant capacity than many other flavanol-rich foods and food extracts such as green and 
black tea, red wine, blueberries, garlic, and strawberry in-vitro [24]. 
This study assessed the benefit of natural cocoa powder (NCP) when given as a regular 
dietary supplement, in preventing liver damage due to chronic ethanol consumption. In the end, 
we reported that alternating (12-hourly) voluntary ingestion of 40% alcohol and 2% aqueous 
suspension of NCP for 12 weeks significantly attenuated structural liver damage in experimental 
rats. This was proven by a 93% preservation of total hepatocytes from an alcohol-induced injury 
when compared to only 23% in the livers of rats that drank water without NCP. 
 
MATERIALS AND METHODS: 
Acquisition and Treatment of Animals: This experimental study was approved by the Ethical 
and Protocol Review Committee of the University Of Ghana Medical School (UGMS) (reference 
number MS-Et/M.5-P.2/2008-09).  Twenty-four male adult Sprague Dawley rats which were 
between  12–14  weeks  old  and  weighed  210–270  g,  were  purchased  from  the  Animal 
Experimentation Department of the Noguchi Memorial Institute for Medical Research (NMIMR) 
in Legon, Accra.  Female rats, being more susceptible to alcoholic hepatotoxicity [25], were 
excluded  because  studies  have  indicated  that  they  were  likely  to  die  before  chronic  effects 
became  evident.    The  rats  were  kept  in  the  animal  experimentation  laboratory  of  NMIMR 
throughout  the  study  under  the  laboratory  conditions  of  temperature  (22  ±  2°C),  relative 
humidity (70 ± 4%), and a 12 hour light/dark cycle. The animals were provided tap water for 
drinking  and  given  nutritionally-standard  rat  food  pellets  obtained  from  Ghana  Agro  Food 
Company  Limited  (GAFCO),  (Tema,  Ghana).  Procedures  involving  the  care  and  use  of  the 
animals were in compliance with national and international laws and guidelines for the use of 
animals in biomedical research. 
Following  one  week  acclimation,  the  rats  were  put  into  three  major  weight–matched 
randomized [26] groups of eight.  The average weights per group prior to any treatment were 
239.4  (SD,  15.0)  g;  240.0  (SD,  13.9)  g;  and  240.5  (SD,  17.9)  g  for  groups  1,  2,  and  3 
respectively.  There were no significant differences between groups when their mean weights 
were compared using one-way ANOVA (df = 2, F = 0.01, p = 0.990).  On account of limited 
facilities for individual handling, rats in each group were placed into two groups of four animals 
per cage (39 cm × 26 cm × 20 cm). 
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Experimental protocol: One group of rats (designated ethanol-water fed or EWF group) was 
given unrestricted access to 200 ml of clean tap water for 12 hours during the daytime (6.00 – 
18.00 hours GMT). The water was replaced with 200 ml of 40 % (v/v) ethanol [27] for the 
following 12-hour period (i.e., 18.00 – 6.00 hours GMT) daily.  A second experimental group of 
rats (designated ethanol-cocoa fed or ECF group) had free access to 200 ml of a 2 % (w/v) 
aqueous  suspension  of  NCP  drink  for  12  hours  during  the  day  (6.00  –  18.00  hours  GMT), 
followed by 200 ml of 40 % (v/v) ethanol drink for the next 12-hour period daily. A third group 
(designated control or C group) had unrestricted access to 200 ml of tap water in two 12-hourly 
changes synchronous with fluid changes for the alcohol-treated animals. The control rats were 
therefore given neither cocoa nor ethanol.  All three groups of rats continued to have free access 
to  nutritionally  standard  GAFCO  rat  food  pellets  ad  libitum.    The  regimen  followed  in  the 
treatment of the animals is shown in Fig. 1.  The respective daily amounts of water and ethanol 
drank by the rats were measured.  Each individual rat was weighed using an animal weighing 
balance (Animal scale, Shinano TS-872, TGC, Japan) at the commencement and termination of 
the experiment. 
 
Preparation  of  2%  (w/v)  aqueous  NCP  and  40%  alcoholic  drink:  A  suspension  of 
GoodFood
® unsweetened natural cocoa powder obtained from Kakawa Enterprise Ltd., Accra, 
Ghana  (batch  number  KK0904A)  was  freshly  prepared  daily  by  weighing  out  8.0  g  on  a 
chemical weighing balance (Mettler Teledo P1200, Switzerland) and then thoroughly dissolving 
it  in  400  ml  of  boiling-hot  tap  water.    With  alcohol  withdrawal  every  morning,  the  freshly 
prepared and cooled 2 % (w/v) aqueous NCP was placed in the cages of the ECF rats.  The NCP 
particles  had  a  tendency  to  sediment,  necessitating  intermittent  agitation  which  made  night 
administration in this study impractical.  The volume of NCP suspension ingested by the rats was 
determined every evening before replacement with ethanol.  Forty percent ethanol solution was 
prepared  daily  by  appropriately  diluting  absolute  ethanol  (99.5  %  [v/v])  (Sigma  Chemical 
Company,  Germany).  The  volume  of  alcoholic  drink  consumed  daily  by  each  rat  was 
determined. 
 
Blood  sampling  and  serum  preparation:  At  commencement  (baseline)  and  12  weeks 
(termination) of experimentation, blood samples were collected from each rat to prepare serum 
for  biochemical  determination  of  their  liver  function.  Approximately  1.5  ml  of  blood  was 
collected via rat tail snipping and gently milking into plain sample bottles with inert separating 
gel (Vacuette {4ml}, Z Serum Sep Clot Activator, Austria).  The blood collected was allowed to 
stand  at  room  temperature  (26 
oC)  for  30  minutes  to  facilitate  clotting  and  to  aid  serum 
preparation.  Tubes containing blood samples were centrifuged for 10 minutes at  3000×g to 
obtain serum.  The serum was decanted by pipetting into Eppendorf tubes (101 – 1000 μl) and 
kept on ice for immediate biochemical analyses. 
 
Biochemical determination  of liver function:  Serum aspartate aminotransferase (AST) and 
alanine  aminotransferase  (ALT)  were  assessed  in  rats  as  biomarkers  of  liver  function.  The 
analyses  were  done  with  a  fully  automated  biochemical  analyzer  (Flexor  E,  Vita  scientific, Functional Foods in Health and Disease 2012, 2(5):166- 187                                                           Page 170 of 187 
 
Netherlands) at NMIMR.  The ratio of AST: ALT was calculated and used to evaluate the extent 
of liver toxicity in all treatment groups. 
 
Harvesting rat liver: Rats were transported from the animal experimentation unit of NMIMR to 
the Histology Laboratory at the University Of Ghana Medical School, Korle Bu, where they 
were sacrificed using established laboratory methods in order to harvest their livers.  Each rat 
was weighed and its blood sample was collected prior to being anaesthetized with chloroform 
(BDH Chemicals Limited, Poole, England). Then, the rats were killed by standard protocol of 
cardiac perfusion fixation using 10% buffered formalin.  Finally, when the liver was dissected 
out, its absolute volume was determined by fluid displacement [28, 29]. 
 
Measurement of hepatosomatic index: The gross liver weight of each rat was determined using 
a Mettler P1200 (Switzerland) weighing balance immediately after the freshly harvested liver 
was blotted dry.  A hepatosomatic index (HSI) was computed by expressing the liver weight as a 
percentage of the rat’s body weight [30] at the termination of the experiment. 
 
Multistage  sampling  of  rat  liver  for  histomorphometry:  Each  liver  was  sampled  using  a 
multistage systematic random technique (Fig. 2).  Firstly, an improvised fractionation grid with 
lines 5.0 mm apart was designed for use in this study.  The liver of each rat was carefully 
separated  into  the  right,  middle,  left  and  papillary  lobes  [30].  Starting  with  the  right  lobe, 
followed by the middle, left and papillary (quadrate) lobes, the liver tissues were sliced with a 
disposable  microtome  blade  into  5.0  mm  thick  slabs  as  indicated  by  a  pilot  study  and  the 
fractionation grid. All the lobes were consistently oriented and fractionated on the grid using a 
common approach.  The liver lobes were fractionated in turns and every third slice was selected, 
starting from a random starting point  (determined by lottery) on the right lobe and working 
progressively to the papillary lobe.  At this first sampling stage, 8–10 slices were obtained from 
each whole liver.   
At the next stage of sampling, the slices were placed across the fractionation grid lines and 
cut in turns (at right angles to their original orientation) into blocks.  These liver blocks were 
then sampled by picking every 11
th block.  The first block was randomly selected and every 11
th 
block was picked.  By this means, three liver blocks were sampled from each whole rat liver.  
Because of the unidirectional method of fractionation and sampling, the three final liver blocks 
sampled were from at least three of the four rat liver lobes.  Variation between sampled blocks 
from each liver frequently came from an exclusion of either the left, or the papillary lobe.  In 
total, 72 blocks were sampled from the 24 rat livers. 
The blocks of liver tissues were taken through standard histological processing protocols in 
order  to  obtain  the  appropriate  sections  necessary.    Paraffin-embedded  blocks  of  liver  were 
sectioned at 5.0 μm thickness using a rotary microtome.  From a random starting point, a total of 
10 sections were systematically sampled by picking every other 20
th section from each tissue 
block, with the distance between successive sections being 100 μm.  These liver sections were 
then placed onto 25.4 mm × 76.2 mm glass slides, 1.0 mm-1.2 mm thick (All Pro, Middlesex, Functional Foods in Health and Disease 2012, 2(5):166- 187                                                           Page 171 of 187 
 
England) prior to being stained with Haematoxylin and Eosin (H & E) and mounted in DPX 
(BDH, Poole, England).  
The next stage of sampling used the liver sections that were previously prepared from 
each group of rats. It was accomplished by initially numbering all the slides, and from a random 
starting point, selecting every 5
th slide.  Ultimately, a total of six slides were sampled from each 
rat liver and used for stereological evaluation. Thirty microscopic fields were then systematically 
and randomly captured [29] from each selected section onto a computer screen with the aid of a 
digital  eye piece  (Premiere MA 88). The  eye piece was  attached to  a  Leica Galen  III  light 
microscope and connected to a computer with Ulead photo explorer 7.0 SE software. 
The diagram below shows the step-wise sampling regime, beginning with the whole rat 
liver through histological blocks and sections for the stereological analysis of micrographs. 
 
 
 
Figure 1: Experimental treatment of rats in the study 
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Figure 2: Illustration of multistage sampling adopted in the study 
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from each slide.  In all, a total of 180 micrographs were obtained from each rat liver. Colored 
paper print versions of the micrographs were made for stereological assessment.  
 
Estimation  of  absolute  volume  of  normal  (undamaged)  hepatocytes:  Determination  of 
absolute  volume  [31]  of  undamaged  hepatocytes  was  done  by  point  counting  and  using  the 
following three main criteria to identify and distinguish visually undamaged hepatocytes from 
damaged  ones:  (i)  cytoplasmic  changes  including  fatty  vesiculation  (visualized  as  histologic 
vacuolation), ballooning cells, and increased eosinophilia, (ii) nuclear changes such as retraction, 
swelling  with  chromatin  aggregation,  pyknosis,  and  karyorrhexis,  and  (iii)  presence  of 
inflammatory cells surrounding hepatocytes [32].  A 1.0 cm square lattice system was used for 
point counting.  This test grid system was printed on an A4 transparency and superimposed onto 
the micrograph printed on paper (Fig.3).  The superimposed test grid and the printed micrographs 
were then secured in position with paper clips during counting. Finally, the square lattice system 
was randomly placed onto each printed photomicrograph (Fig. 3), the number of test points 
falling  on  undamaged  hepatocytes  (Px)  was  recorded.  The  number  of  points  falling  on  all 
hepatocytes was also recorded (Py). The absolute volume of undamaged hepatocytes (AVUnhep) 
for each micrograph was estimated as follows: 
 
[AVUnhep = (Px/Py) × Absolute liver volume (cm
3)] 
 
The  above  equation  was  used  to  determine  the  degree  of  hepatic  preservation  in  all  animal 
treatment groups in this study. 
 
Statistical analyses: Microsoft Statistical Package for the Social Sciences (SPSS) Version 16.0 
for Windows was used for statistical analyses.  All analyzed data results were expressed as mean 
and  standard  deviation  (SD).    Confidence  intervals  (95%  CI)  for  means  were  appropriately 
reported, and statistical significance of the differences between group means was performed by a 
one-way analysis of variance [ANOVA] (between and within subjects) followed by a Post Hoc 
Test (Tukey’s HSD).  Differences with p < 0.05 were considered to be significant 
 
 
Figure 3: Test lattice grid superimposed on a micrograph of rat liver 
A 
B 
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D Functional Foods in Health and Disease 2012, 2(5):166- 187                                                           Page 174 of 187 
 
A photomicrograph of a test grid with a 1.0 cm
2 lattice superimposed on a micrograph of rat liver for the 
stereological estimation of undamaged hepatocytes.  A- Test point hitting a damaged hepatocyte.  B- 
Hepatocyte with a laterally displaced nucleus, C- Nucleus of leucocyte, and D- Binucleated undamaged 
hepatocyte. 
 
RESULTS: 
Fluid intake by rats: On a daily basis, ECF rats imbibed a median average of 30 ml of alcohol 
per animal compared with 25 ml for EWF rats which gave a Levene’s test p = 0.001.  Mann-
Whitney U-test comparison yielded U = 1301.0, N1 = 70, N2 = 70, p = 0.0005, two- tailed.  
EWF rats drank a median average of 30 ml water per rat per day as against 25 ml by Control rats 
and had Levene’s test p = 0.001.  Mann-Whitney U = 793.0, N1 = 7-, N2 = 70, p = 0.0005, two-
tailed.  Each ECF rat imbibed a median volume of 45 ml per day. 
 
Biomarkers of liver function: Animals given access to ethanol had elevated serum AST and 
ALT  ratios.    At  the  termination  of  the  experiment,  the  AST/ALT  ratios  were  significantly 
different among the three rat groups studied (one-way ANOVA: df = 2, F = 11.747; p < 0.0005).   
Multiple comparison tests (Tukey’s HSD) on AST/ALT ratio data are summarized in Table 1. 
 
Table 1: Results of statistical comparisons of serum AST/ALT ratio of rats in 3 groups studied 
 
Treatment group  Mean  SD 
 
95%  CI  for 
the mean 
p-value 
(Tukey’s 
HSD) 
         
EWF 
a 
 
1.83  0.38  1.51 – 2.14  0.095 
ab 
ECF 
b 
 
1.51  0.23  1.31 – 1.71  0.039 
bc 
Control 
c 
 
1.13  0.22  0.95 – 1.32  0.0005 
ca 
 
SD = standard deviation of the mean;  CI = confidence interval;  Superscript ab  = comparison 
between groups a and b; applies respectively to bc and ca. 
 
Body weight (Bwt) of rats: The average weights of the rats at the end of the experiment were 
significantly different among the three rat groups (one-way ANOVA: df = 2, F = 3.902, p = 
0.036).  Mean weight for the EWF group was 302.3 g (SD 22.0 g) (95% CI: 283.9–320.6 g), 
which for the ECF group was 312.3 g (SD 20.3 g) (95% CI: 295.5–329.0 g), and for the control 
group was 334.3 g (SD 27.6 g) (95% CI: 311.1–357.4 g).  A test of within-subjects effects for 
duration of alcohol administration at the baseline, midway and end of the experiment, yielded 
significant differences (one-way repeated measures ANOVA: F = 106.067, p = 0.0005, partial η
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= 0.822).  Tukey’s HSD post hoc multiple comparison test on the means of rat weight at the 
termination of the experiment yielded a significantly higher value (p = 0.032) when the control 
group was compared with the EWF group.  A similar comparison of control rats with the ECF 
group produced a non- significant difference in their mean weights (p = 0.170).  When the same 
statistical test was performed on the terminal weight of the EWF group compared with the ECF 
group, a p-value of 0.675 was obtained, indicating again a non-significant difference.   
 
Hepatosomatic index (HSI): One way ANOVA yielded an F statistic of 9.020 (p = 0.001) when 
the hepatosomatic indices studied were finally compared. This indicated significant differences 
among the three groups. Multiple comparison tests (Tukey’s HSD) on HSI data are summarized 
in Table 2. 
 
Table 2: Synopsis of statistical analyses of hepatosomatic indices among the 3 groups of rats 
studied. 
 
Treatment  
group 
Mean (%) 
 
SD 
 
95% CI for the 
mean 
 
p-value 
(Tukey’s 
HSD) 
         
EWF 
a 
 
4.7  0.8  4.0 – 5.4  0.105 
ab 
ECF 
b 
 
4.1  0.4  3.7 – 4.4  0.113 
bc 
Control 
c 
 
3.4  0.5  3.1 – 3.8  0.001 
ca 
 
SD = standard deviation of the mean; CI = confidence interval; Superscript ab = comparison between 
groups a and b; applies respectively to bc and ca. 
 
Gross liver volume at termination of experiment: The average gross liver volume for the 
control group of rats was 10.9 ml (SD 1.5) ml, of which that of the EWF group was 12.4 ml (SD 
1.8 ml), and that of the ECF group was 11.5 ml (SD 1.9 ml). This comparison of gross liver 
volume in these three groups of rats by ANOVA yielded p = 0.219, indicating a lack of statistical 
significance among them. 
 
Histologically assessed liver injury: The normal histological structure of the liver parenchyma 
(Fig.  4A)  was  observably  disrupted  in  rats  that  were  given  ethanol  (Figs.  4B  &  4C).  
Qualitatively,  the  injury  to  liver  micro-structure  was  less  severe  in  the  ECF  rats  (Fig.  4B) 
compared with the EWF group (Fig. 4C).  Hepatocytes in the liver of EWF rats exhibited more 
than  two  of  the  criteria  used  to  identify  and  score  hepatotoxicity  in  this  study,  notably  (i) 
conspicuous cytosolic changes involving fatty vesiculations (appearing as vacuolations), and (ii) Functional Foods in Health and Disease 2012, 2(5):166- 187                                                           Page 176 of 187 
 
nuclear  changes  represented  by  pleomorphism,  retraction,  and  displacement  (Fig.  4C).  The 
patterns of morphological changes and structural perturbations seen by observation between the 
groups were identified in about 60 % of all the treatment groups assessed.  Ethanol toxicity also 
caused  noticeable  pericentral  hepatic  disruption  of  typical  radial  arrangement  of  sheets  of 
hepatocytes from the central venule.  Periportal assessment of morphological changes revealed 
general distortion and fatty infiltration in the connective tissue, which was absent in normal 
controls and minimized in ethanol-cocoa fed rat liver as compared to ethanol-water fed rat liver.  
 
Stereologically  assessed  liver  injury:  Stereologically  determined  absolute  volume  of 
undamaged  (preserved)  hepatocytes  yielded  the  results  that  are  shown  in  Fig.  5.    One  way 
ANOVA indicated that differences in means were significant (F = 56.127, p = 0.0005).  Tukey’s 
HSD  post  hoc  multiple  comparison  tests  (Table  3)  confirmed  that  the  absolute  volume  of 
undamaged hepatocytes was statistically lower in EWF rats compared with control rats.  Table 3 
also shows that the absolute volume of undamaged hepatocytes was statistically higher in ECF 
group of rats when compared with EWF group. However, there was no statistical difference 
between the absolute volume of preserved hepatocytes in ECF and control rats (Table 3).  
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(A) Sinusoids (sn) run between the linear cords (lc) of hepatocytes in the liver of a control rat. 
(B)  Apparently unperturbed sinusoids (sn) and mildly perturbed linear cords (lc) of hepatocytes 
in  the liver of an ECF rat.   (C) Apparently dilated sinusoids  (dsn), distortions  in  the linear 
arrangement  of  hepatocytes,  an  increased  number/size  of  cytoplasmic  vesiculations  (yellow 
arrows), and nuclear displacement (dark arrows).  Note that dispersed small vesiculations are 
normal in the liver and represent endogenous stores of fat as energy depots [61]. 
 
Table  3:  Summarized  analyses  of  absolute  volume  of  undamaged  hepatocytes  among  the  3 
groups of rats studied. 
 
Treatment group  Mean in 
ml 
SD 
 
95%  CI  for 
mean 
p-value 
(Tukey’s 
HSD) 
         
EWF 
a 
 
2.34  1.21  1.33 – 3.35  0.0005 
ab 
ECF 
b 
 
9.61  2.18  7.79 – 11.43  0.659 
bc 
Control 
c 
 
10.34  1.47  9.11 – 11.58  0.0005 
ca 
 
SD = standard deviation; CI = confidence interval; Superscript ab = comparison between groups a and b; 
applies respectively to bc and ca. 
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Absolute volumes  of undamaged hepatocytes  in all  groups of  rats assessed by design-based 
stereology from micrographs such as those presented in Fig. 4.  Error bars represent standard 
deviations; data was obtained from 180 micrographs per liver and eight animals in each group. 
 
DISCUSSION:  
The  main  focus  of  this  study  was  to  test  the hypothesis  that  natural  cocoa  ingestion  would 
minimize  alcoholic  liver  damage  in  experimental  rats.    Given  the  established  pathogenic 
contribution of oxidative stress in the development of alcoholic liver disease [3, 7, 21], it was 
expected  that  the  antioxidant  properties  of  cocoa  polyphenols  [33]  would  ameliorate 
experimentally- induced ethanol hepatotoxicity in rats.  The plausibility of this hypothesis was 
elicited by the previously reported benefits of resveratrol, a red wine polyphenol, in attenuating 
the oxidative stress effect on alcohol metabolism in the liver of experimental animals [6, 25].  
Natural  cocoa was  used in  the present  study because it contains  the highest  levels  of Total 
Antioxidant Capacity (TAC) and procyanidins when compared with other edible cocoa products 
[34].  The 2% (w/v) of NCP used in this study is the most widely tolerated concentration for 
human consumption without sugar or any other additive (FKA, unpublished observations). 
In agreement with earlier studies, our study showed that the serum concentration of AST 
and ALT was raised in rats given ethanol, demonstrating that these liver enzymes significantly 
increased during excessive consumption of alcohol [6, 35, 36].  The diagnostic significance of a 
high AST/ALT ratio for alcoholic liver disease was emphasized in the Practical Guidelines for 
Alcoholic Liver Disease, published by the American College of Gastroenterology in 1998 [37].  
When the AST/ALT ratio is ≥ 2, it indicates advanced liver disease [38].  Although the EWF rats 
in the present study had the highest AST/ALT ratio of 1.83 (SD = 0.38), it was still not ≥ 2, 
implying that only moderate liver damage was caused. This is probably because the voluntary 
oral mode of ethanol administration in this experiment did not achieve a high and sustained 
blood alcohol level which is a prerequisite for the establishment of advanced alcohol-induced 
liver injury [39].  
It is important in the context of the main focus of the present study, that regular NCP 
consumption attenuated an increase of the AST/ALT ratio in ECF rats.  This group’s relatively 
lower AST/ALT ratio [1.25 (SD 0.18)] compared with EWF rats suggests that cocoa ingestion 
limited  pathologic  release  of  serum  AST  and  ALT  in  vivo.    The  increased  activities  of  the 
enzymes  AST  and  ALT  in  serum  indicate  hepatocellular  damage  since  the  levels  of  these 
enzymes are raised in acute hepatoxicity [40].  Our findings that ALT and AST levels were 
lower  in  ECF  rats  compared  to  EWF  rats  affirms  the  implied  hepatoprotective  activity  of 
components in cocoa. Furthermore, it has been reported [41] that antioxidants reduce AST and 
ALT levels in experimental rats and mice with liver disorders.   For example, the extract of 
Antrodia camphorata (an antioxidant) has been reported to ameliorate the increase of ALT and 
AST levels caused by chronic repeated CCL4 intoxication in mice by mediating antioxidative and 
free radical scavenging activities [42]
.   Our finding that serum AST and ALT elevation was 
apparently milder than quantified hepatocyte injury, invites an inference that these functional 
markers are less acute indicators of hepatic damage than structural disruption, and/or may lag 
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be anti-inflammatory [15] and antioxidant [21] mediation by cocoa flavanols which thus reduces 
a  subsequent  generation  of  free  radicals  during  alcohol  metabolism  [5].    Support  for  this 
postulate  is  obtained  from  studies  similar  to  the  present  report.  One  such  study  involved 
streptozotocin (STZ) –induced diabetic rats that were given 2% NCP over 13 weeks [43].  In the 
latter work, the concentration of plasma isoprostane (F2-IsoPs), an oxidative marker, rose by 
43.82% in STZ-induced diabetic rats and 9.14% in STZ-induced diabetic rats that voluntarily 
ingested cocoa as a drink, signifying a 34.68% decrease in the plasma oxidative marker. 
After being fed a cocoa-enriched diet, the total antioxidant capacity (TAC) and activity of 
antioxidant enzymes (superoxide dismutase and catalase), has been shown to be enhanced in the 
liver tissue of young rats that were chronically exposed to ethanol [44].  In the STZ-induced 
diabetic rats study cited above [43],  total antioxidant power (TAP) of testicular tissue measured 
as a uric acid equivalent, decreased by 80.5% in animals not given cocoa and 43.4% in animals 
given 2% NCP over 13 weeks.  This indicated that ingestion of NCP was associated with 37.1% 
retention of TAP in the testicular tissue of the STZ-induced diabetic rats.  
The  antioxidant  defense  of  quercetin,  a  constituent  of  natural  cocoa,  against  oxidative 
stress action is the main mechanism of its protective effect on ethanol-induced liver injury [45]. 
An assessment of the protective effect of quercetin on ethanol-induced acute liver injury in rats 
concluded  that  hepatoprotectivity  can  be  achieved  by  eating  foods  rich  in  quercetin  [45].  
Therefore,  it  is  noteworthy  that  quercetin  had  the  highest  peak  in  the  preliminary  tests  for 
antioxidant content in the NCP used for the present study [17]. 
Rats in all treatment groups gained weight throughout the experiment.  However, EWF rats 
gained the least weight when compared with ECF and control rats.  Ingested cocoa can prevent 
high-fat diet–induced obesity by modulating lipid metabolism, especially by decreasing fatty 
acid synthesis and transport systems, and enhancing part of the thermogenesis mechanism in 
liver and white adipose tissue [46].  It is therefore reasonable to infer that the weight gained by 
ethanol-cocoa treated rats was not due to cocoa ingestion (caloric effect).  Rather, it is speculated 
that NCP intake was in fact able to limit the toxic effect of alcohol, which would in most cases 
lead to systemic dehydration, reduced food intake, and ceased or reduced growth rate [47].  The 
latter effect of alcohol ingestion may partly account for the lower weight of EWF rats at the 
termination of the present study. 
A common variable, hepatosomatic index (HSI), is usually used to assess change in gross 
liver weight with respect to the overall body weight [27]. The liver indices of the experimental 
rats were markedly affected by ethanol ingestion and regular consumption of natural cocoa drink. 
The  results  of  this  study  showed  significantly  higher  HSI  in  EWF  rats  when  compared  to 
controls. Conversely there was an absence of difference in HSI between ECF rats and controls. It 
is also notable that even though there was a significantly greater volume of alcohol consumption; 
ECF rats produced milder hepatic damage than EWF rats. This was confirmation that cocoa 
ingestion did not eliminate or prevent but minimized liver damage caused by alcohol.   
In this study, the oral administration and voluntary drinking of alcohol by rats may account 
for the absence of pathology beyond hepatic fatty changes. This is because simple inclusion of 
ethanol in drinking fluid rarely causes high and sustained elevation of blood ethanol levels and 
only a moderate rise in liver triglycerides is observed [48]. Given that it was the aim of this study Functional Foods in Health and Disease 2012, 2(5):166- 187                                                           Page 180 of 187 
 
to  mimic  human  alcoholism  well  enough  in  experimental  rats,  the  mode  of  ethanol 
administration used is defensible. On the other hand, considering the close resemblance of a rat 
liver’s microstructure to that of a human’s [49], results obtained from hepatological studies of 
this  kind  in  experimental  rats  may  be  extrapolated  to  humans  with  potential  application  in 
clinical trials.  
In humans, chronic ethanol consumption leads to a characteristic set of changes in the 
metabolism  of  lipids  in  the  liver.  This  is  referred  to  as  an  alcoholic  fatty  liver  [50].    This 
condition is characterized by an increase in liver weight [51], an accumulation of triglycerides, 
and changes in expression of genes involved in lipid metabolism [52].  In severe cases, these 
changes eventually lead to inflammation [53] and steatohepatitis [54].  Most of these changes are 
also observed in rodents [55], justifying the use of chronic alcohol exposure in rodents as a 
model to understand the human condition. 
In  agreement  with  the  documented  antioxidant,  anti-inflammatory,  and  anti-obesity 
properties  of  cocoa,  it  was  histologically  observed  that  ECF  rats  had  more  undamaged 
(preserved) hepatocytes in their liver that EWF rats in spite of a chronic consumption of alcohol.  
Due  to  the  fact  that  EWF  rats  were  not  given  NCP  drink,  their  liver  parenchyma  was 
significantly more damaged structurally in comparison to the control rats and the ECF group 
(Figure  5).    The  structural  evidence  affirmed  the  functional  deficits  in  AST  and  ALT  as 
discussed above.   It is suggested that the anti-inflammatory and antioxidant effects of NCP, 
minimized  cellular  damage  from  ethanol  metabolism  by  reducing  the  intensity  of  fatty 
vesiculation in the livers of ECF rats compared with EWF rats. This was a result of beneficial 
modulation of the de
 novo fatty acid biosynthetic pathways.  
In recent years, researchers have used design-based stereology for the study of rat livers 
[56, 57, 58]. This has established appropriate quantification strategies for obtaining unbiased 
estimates of liver cells and structure. This constitutes a new solid quantitative background in 
normal  and  pathologic  conditions.    This  is  relevant  for  establishing  morphofunctional 
correlations and for monitoring the progression of inflammatory and fibrotic liver conditions 
[59].    In  fact,  although  advances  in  cell  isolation  and  molecular  biology  have  contributed 
significantly to the current understanding of the role of both parenchymal and non-parenchymal 
cells in hepatic injury, in vivo morphological examination continues to be the most effective and 
powerful means for investigating the cellular interplay between structure and function [60].  
The systematic and random approach used in sampling and subsequent quantification of 
hepatocyte preservation made it possible to study and stereologically evaluate liver damage in all 
four liver lobes of the rats in the treatment groups. A decreased amount of normal hepatocytes in 
the liver of the ethanol-water treated rats rationalizes the reduced functionality, delineated by a 
high AST/ALT ratio, and undesirable alteration in their liver structure. This was a result of the 
alcoholic insult.  It is inferred from the present study that voluntary NCP intake significantly 
reduced the steatotic effect of the alcoholic drink used to establish ethanol toxicity. Therefore, 
judging from the results of the stereological assessment (Table 3), it is affirmed that regular 
intake of NCP drink exerted hepatoprotective benefits. This slowed the rate of structural damage 
and alcohol induced indications of liver damage. Concomitantly, NCP also improved the lipid 
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Conclusion:  Ethanol-mediated
  pathologic  alterations  in  hepatic  morphology  and  functional 
deficits due to voluntary ingestion of 40% (v/v) of ethanol in rats have been established. At the 
same time, the possible prophylactic benefits of NCP in slowing down liver
 injury arising from 
chronic  ethanol  consumption  have  also  been  demonstrated.  Inferentially,  the  early  phase  of 
alcohol-induced  liver  damage  may  be  significantly  attenuated  by  NCP  consumption.  This  is 
possibly  afforded  by  anti-inflammatory  and  antioxidant  augmentation  against  damage  to 
hepatocyte morphology and metabolism.  
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